Palo Alto, CA
- Tweets 1,336
- Following 383
- Followers 1,687
- Likes 1,377
Last call! Attention to all our dedicated followers and partners. We’re moving all activity over to @invitae. Stay connected with the Inviate Ciitizen community by following us @Invitae.
2
5
Thank you to all our dedicated followers and partners! We’re moving all activity over to @Invitae. We remain committed to enabling patients more control over their own health records for their personal care coordination needs. Follow us @Invitae
5
Have you followed @Invitae yet? Stay connected with the Invitae Ciitizen community by following us @Invitae.
1
Have you heard? We’re moving over to @Invitae. Stay connected with the Invitae Ciitizen community by following us @Invitae.
2
8
Big news! We’re closing this account, but you can still follow us over at @Invitae.
Thank you to all our dedicated followers and partners. We remain committed to enabling patients more control over their own health records for their personal care coordination needs.
3
11
Ciitizen retweeted
👋 Friendly Reminder: #SYNGAP Seizure Tracker Study
This is happening!
Sign up for Ciitizen at Ciitizen.com/Syngap1
Log in at: app.Ciitizen.com
@ciitizen @invitae
#Studies #careaboutrare #rarediseaseresearch #syngap1
3
7
Ciitizen retweeted
As a team built of #rare parents, we’re proud to sponsor this initiative. We're grateful to your organization & the #SYNGAP1 community who are proactively gathering and sharing invaluable insights and using tools like @Ciitizen/@Invitae to help us move innovation forward quickly.
8
14
Ciitizen retweeted
“We were literally handed the raw data immediately”@PraxisMedicines on sourcing @cureSYNGAP1 data on @ciitizen and @Invitae! 💃🏻Also, still the handsomest little fella on that front page 😍 Thanks @JMGraglia, @McNamarVirginie, and team for making us a highly recruitable bunch!
1
11
36
Ciitizen retweeted
News! @PraxisMedicines, who's developing an #ASO for #SYNGAP1 (#S10e58 @ Syngap.Fund/E58) is launching a study in partnership with #SRF & @ciitizen/@Invitae. Join us THIS Thurs to learn more. Register @ Syngap.Fund/Tracker. Ciitizen registry: Ciitizen.com/Syngap1
7
11
We're proud to partner with the Cholangiocarcinoma Foundation to help patients control their health data. Join this important research today: bit.ly/3IoumH8 @curecc
2
4
23
Join Invitae's Ciitizen clinical study to improve medical research for 22q11.2 deletion syndrome. bit.ly/3OSiUGv
1
5
We believe in patient-first research to improve future outcomes. Explore our current research opportunities and join us today to experience the free, secure benefits of Invitae’s Ciitizen. bit.ly/3NL86ZB
2
9
We are excited to join @FamilieSCN2A at the #SCN2A Summer Seminar in-person this year, July 28-29th! Learn more about our SCN2A research study available now bit.ly/3J2fPl3
#epilepsy #geneticepilepsy #genetictesting
Our PCDH19-Related Epilepsy Digital Natural History Study is now recruiting patients. Learn how to participate in this important research here: bit.ly/3uHveAh
2
We're working with the Cholangiocarcinoma Foundation to improve the lives of #cholangiocarcinoma patients by accelerating research. Join us today. bit.ly/3MRvpjH @curecc
3
9
Time is running out, don’t forget to register for our latest webinar, July 12th at 4:30pm PT. Learn about the benefits of Invitae’s Ciitizen and the neuro research opportunities available. Register: bit.ly/3bUzxCD
2
7
Sarcomas are rare, aggressive cancers that grow in the bones, muscles and soft tissues. They're often diagnosed too late for effective treatment or even misdiagnosed. That's why July is #sarcomaawarenessmonth. Learn more the @Reininsarcoma Foundation. bit.ly/3bPdRI8
7
Join Invitae’s Ciitizen and the Cholangiocarcinoma Foundation on July 12th at 5:30pm ET for a webinar about the research opportunities available now. Register here today! bit.ly/3at3xoT @curecc #cholangiocarcinoma
4
6
Don’t miss our latest webinar! Learn more about the benefits of joining the Invitae Ciitizen community. Our research team is ready to answer your questions, July 12th 4:30pm ET. Register today: bit.ly/3RmPUs3
3